lidoflazine has been researched along with Potassium Deficiency in 1 studies
Lidoflazine: Coronary vasodilator with some antiarrhythmic action.
Potassium Deficiency: A condition due to decreased dietary intake of potassium, as in starvation or failure to administer in intravenous solutions, or to gastrointestinal loss in diarrhea, chronic laxative abuse, vomiting, gastric suction, or bowel diversion. Severe potassium deficiency may produce muscular weakness and lead to paralysis and respiratory failure. Muscular malfunction may result in hypoventilation, paralytic ileus, hypotension, muscle twitches, tetany, and rhabomyolysis. Nephropathy from potassium deficit impairs the concentrating mechanism, producing POLYURIA and decreased maximal urinary concentrating ability with secondary POLYDIPSIA. (Merck Manual, 16th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carmeliet, E | 1 |
| Xhonneux, R | 1 |
| Reneman, RS | 1 |
1 other study available for lidoflazine and Potassium Deficiency
| Article | Year |
|---|---|
Lidoplazine and Na and K distribution in normo-and hypokalaemic rats.
Topics: Animals; Body Water; Body Weight; Diaphragm; Erythrocytes; Extracellular Space; Heart; Heart Atria; | 1975 |